University of Sussex
Carrier Effect in Development of Rifampin Loaded Proliposome for Pulmonary Delivery A Quality by Design Study.pdf (1 MB)
Download file

Carrier effect in development of rifampin loaded proliposome for pulmonary delivery: a quality by design study

Download (1 MB)
journal contribution
posted on 2023-06-10, 05:05 authored by Elahehnaz Parhizkar, Delaram Sadeghinia, Hamed Hamishehkar, Shadi Yaqoubi, Ali Nokhodchi, Shohreh Alipour
Purpose: Pulmonary tuberculosis (TB) is a worldwide life-threatening infection. The recommended anti-TB regimen contains oral administration of classical first-line drugs such as rifampin for 6-24 months which often leads to low patient compliance due to high adverse effects; therefore, lung localized pulmonary delivery of anti-TB agents may be a suitable alternative. Proliposomes free-flowing powders are well-known carriers for lung delivery since they can form liposomes by hydration. Liposomes are safe and useful carriers for lung delivery due to their phospholipid structure. Methods: Porous lactose and mannitol as proliposome carriers were prepared by spray drying technique using sucrose and citric acid as templating agents. Design Expert® software was used to develop forty formulations based on the porous and non-porous carriers, which were characterized with respect to their weight yield, density, and flowability. Rifampin-loaded hydrated liposomes were produced and evaluated for size, morphology, loading capacity and encapsulation efficiency. The optimized proliposomes in vitro release and aerosolization properties were evaluated. Solid-state analysis was confirmed by differential scanning calorimetry (DSC). Results: Porous lactose surface area was 80 folds higher than non-porous one, respectively. Optimized porous-based proliposome indicated the acceptable aerosolization properties, including mass median aerodynamic diameter (MMAD) of 6.21 ± 0.36 µm and fine particle fraction (FPF) of 9.17 ± 0.18% with a fast rifampin release (80%) within one hour. DSC results proved that there was no change in the solid-state of rifampin during the production process. Conclusion: Hence, it seems; rifampin loaded inhalable proliposomes may be a suitable system for delivering liposomal rifampin into the lungs.


Publication status

  • Published

File Version

  • Published version


Advanced Pharmaceutical Bulletin




Maad Rayan Publishing Company





Page range


Event location


Department affiliated with

  • Chemistry Publications

Full text available

  • Yes

Peer reviewed?

  • Yes

Legacy Posted Date


First Open Access (FOA) Date


First Compliant Deposit (FCD) Date


Usage metrics

    University of Sussex (Publications)


    No categories selected